NANOVIRICIDES, INC. Current Liabilities
NANOVIRICIDES, INC. (NNVC) had Current Liabilities of $1.07 million as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-05-15
- 2026-03-31: Liabilities, Current $1.07M.
- 2025-12-31: Liabilities, Current $1.20M.
- 2025-09-30: Liabilities, Current $1.18M.
- 2025-06-30: Liabilities, Current $1.31M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-03-31 | $1.07M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $1.20M 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $1.18M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.31M 10-Q · filed 2026-05-15 | |
| 2025-03-31 | $1.20M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.18M 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $1.63M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $1.36M 10-K · filed 2025-09-29 | |
| 2024-03-31 | $813.34K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $951.07K 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $948.31K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $534.25K 10-K · filed 2024-09-27 | |
| 2023-03-31 | $348.74K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $464.59K 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $518.36K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $412.84K 10-K · filed 2023-10-13 | |
| 2022-03-31 | $386.73K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $344.29K 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $869.47K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $351.15K 10-K · filed 2022-10-13 | |
| 2021-03-31 | $871.34K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $339.31K 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $1.87M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $2.16M 10-K · filed 2021-10-12 | |
| 2020-03-31 | $2.21M 10-Q · filed 2020-06-22 | |
| 2019-12-31 | $3.90M 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $2.66M 10-Q · filed 2019-11-15 | |
| 2019-06-30 | $2.85M 10-K · filed 2020-10-13 | |
| 2019-03-31 | $1.08M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $1.16M 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $1.39M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $881.95K 10-K · filed 2019-08-23 | |
| 2018-03-31 | $3.19M 10-Q · filed 2018-05-21 | |
| 2017-12-31 | $6.74M 10-Q · filed 2018-02-20 | |
| 2017-09-30 | $5.28M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $4.67M 10-K · filed 2018-10-12 | |
| 2017-03-31 | $331.64K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $6.32M 10-Q · filed 2017-02-14 | |
| 2016-09-30 | $6.94M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $6.74M 10-K · filed 2017-09-28 | |
| 2016-03-31 | $6.62M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $1.47M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $983.09K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $600.89K 10-K · filed 2016-09-16 | |
| 2015-03-31 | $523.43K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $1.12M 10-Q · filed 2015-02-25 | |
| 2014-09-30 | $752.89K 10-Q/A · filed 2015-02-23 | |
| 2014-06-30 | $517.74K 10-K · filed 2015-09-14 | $1.23M 10-K · filed 2014-09-30 |
| 2014-03-31 | $1.21M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $1.36M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $1.87M 10-Q/A · filed 2015-02-23 | |
| 2013-06-30 | $1.18M 10-K · filed 2015-02-23 | |
| 2013-03-31 | $4.41M 10-Q/A · filed 2013-05-20 | |
| 2012-12-31 | $1.40M 10-Q/A · filed 2013-02-22 | |
| 2012-09-30 | $1.56M 10-Q · filed 2012-11-19 | |
| 2012-06-30 | $1.78M 10-K/A · filed 2013-10-08 | |
| 2012-03-31 | $804.07K 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $1.17M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $991.16K 10-Q/A · filed 2011-12-12 | |
| 2011-06-30 | $587.18K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |